GlassScriptPhysician profile
Lisa M Mcintosh
NPI 1407941578
$692.17
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $98.89 · 2021: $122 · 2022: $231 · 2023: $66.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $66.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $66.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $267.18 | 2019-2022 | |
| Exeltis, USA INC. | $112.96 | 2021-2023 | Slynd |
| Coopersurgical, INC. | $51.27 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $48.04 | 2020-2022 | |
| Roche Diagnostics Corporation | $39.73 | 2019-2020 | |
| Conmed Corporation | $32.27 | 2019 | |
| Organon LLC | $32.19 | 2022 | |
| Agile Therapeutics, INC. | $28.49 | 2022-2023 | Twirla |
| Intuitive Surgical, INC. | $16.55 | 2019 | |
| Millicent US INC | $14.93 | 2023 | Intrarosa, Femring |
| Avion Pharmaceuticals | $13.74 | 2022 | |
| Smith+Nephew, INC. | $12.38 | 2022 | |
| Emmaus Medical, INC. | $11.32 | 2020 | |
| Myovant Sciences INC. | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Mcintosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.